Halozyme Therapeutics, Inc.
(HALO - NASDAQ)
65,29 USD
📋 Profilo Aziendale

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally.

|